Literature DB >> 33021069

Somatotropic-Testicular Axis: A crosstalk between GH/IGF-I and gonadal hormones during development, transition, and adult age.

Marta Tenuta1, Francesco Carlomagno1, Biagio Cangiano2, George Kanakis3, Carlotta Pozza1, Emilia Sbardella1, Andrea M Isidori1, Csilla Krausz4, Daniele Gianfrilli1.   

Abstract

BACKGROUND: The hypothalamic-pituitary-gonadal (HPG) and hypothalamic-pituitary-somatotropic (HPS) axes are strongly interconnected. Interactions between these axes are complex and poorly understood. These interactions are characterized by redundancies in reciprocal influences at each level of regulation and the combination of endocrine and paracrine effects that change during development.
OBJECTIVES: To comprehensively review the crosstalk between the HPG and HPS axes and related pathological and clinical aspects during various life stages of male subjects.
MATERIALS AND METHODS: A thorough search of publications available in PubMed was performed using proper keywords.
RESULTS: Molecular studies confirmed the expressions of growth hormone (GH) and insulin-like growth factor-I (IGF-I) receptors on the HPG axis and reproductive organs, indicating a possible interaction between HPS and HPG axes at various levels. Insulin growth factors participate in sexual differentiation during fetal development, indicating that normal HPS axis activity is required for proper testicular development. IGF-I contributes to correct testicular position during minipuberty, determines linear growth during childhood, and promotes puberty onset and pace through gonadotropin-releasing hormone activation. IGF-I levels are high during transition age, even when linear growth is almost complete, suggesting its role in reproductive tract maturation. Patients with GH deficiency (GHD) and insensitivity (GHI) exhibit delayed puberty and impaired genital development; replacement therapy in such patients induces proper pubertal development. In adults, few studies have suggested that lower IGF-I levels are associated with impaired sperm parameters. DISCUSSION AND
CONCLUSION: The role of GH-IGF-I in testicular development remains largely unexplored. However, it is important to evaluate gonadic development in children with GHD. Additionally, HPS axis function should be evaluated in children with urogenital malformation or gonadal development alterations. Correct diagnosis and prompt therapeutic intervention are needed for healthy puberty, attainment of complete gonadal development during transition age, and fertility potential in adulthood.
© 2020 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  IGF-I; growth hormone; growth hormone deficiency; puberty; testicle; transition age

Year:  2020        PMID: 33021069     DOI: 10.1111/andr.12918

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  8 in total

1.  Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study.

Authors:  T Feola; R Sa Pirchio; G Puliani; R Pofi; M Crocco; V Sada; F Sesti; F Verdecchia; D Gianfrilli; M Appetecchia; N Di Iorgi; M L Jaffrain-Rea; R Pivonello; A M Isidori; A B Grossman; E Sbardella
Journal:  J Endocrinol Invest       Date:  2022-08-24       Impact factor: 5.467

2.  MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis.

Authors:  Fabio Bioletto; Nunzia Prencipe; Alessandro Maria Berton; Chiara Bona; Mirko Parasiliti-Caprino; Riccardo Faletti; Ezio Ghigo; Silvia Grottoli; Valentina Gasco
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

3.  Sexual Dysfunction: A Neglected and Overlooked Issue in Adult GH Deficiency: The Management of AGHD Study.

Authors:  Maria Laura Monzani; Simone Pederzoli; Laura Volpi; Elisa Magnani; Chiara Diazzi; Vincenzo Rochira
Journal:  J Endocr Soc       Date:  2021-01-13

Review 4.  Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone Deficiency During the Transition Period: Review of the Literature.

Authors:  Matteo Spaziani; Chiara Tarantino; Natascia Tahani; Daniele Gianfrilli; Emilia Sbardella; Andrea M Isidori; Andrea Lenzi; Antonio F Radicioni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 5.555

Review 5.  GH Deficiency and Replacement Therapy in Hypopituitarism: Insight Into the Relationships With Other Hypothalamic-Pituitary Axes.

Authors:  Eriselda Profka; Giulia Rodari; Federico Giacchetti; Claudia Giavoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-19       Impact factor: 5.555

6.  Growth Hormone Is Beneficial for Induction of Spermatogenesis in Adult Patients With Congenital Combined Pituitary Hormone Deficiency.

Authors:  Yiyi Zhu; Min Nie; Xi Wang; Qibin Huang; Bingqing Yu; Rui Zhang; Junyi Zhang; Bang Sun; Jiangfeng Mao; Xueyan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

7.  Significance of recombinant human growth hormone therapy in promoting growth and development of children with idiopathic short stature.

Authors:  Wenbiao Han; Jing Zhang; Tao Song; Yanni Han
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

8.  Role of the GH-IGF1 axis on the hypothalamus-pituitary-testicular axis function: lessons from Laron syndrome.

Authors:  Rossella Cannarella; Andrea Crafa; Sandro La Vignera; Rosita A Condorelli; Aldo E Calogero
Journal:  Endocr Connect       Date:  2021-08-25       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.